ImmunoCellular (IMUC) to Present at the 16th Annual Meeting of the Society...
November 18, 2011 ImmunoCellular Therapeutics Ltd. (OTCBB: IMUC), a biopharmaceutical company developing new therapeutics to fight cancer using the immune system, is taking a different approach than...
View ArticleA New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for...
press release Nov. 25, 2011, 6:57 a.m. EST GOTHENBURG, Sweden, November 25, 2011 /PRNewswire via COMTEX/ — Immunicum, which is developing cancer vaccines, has received approval from the Swedish...
View Articleactivation of antitumor cytotoxic T lymphocytes by fusion of patient-derived...
Experimental Oncology 27, 273-278, 2005 (December) 273 Z. Yu*, B. Ma, Y. Zhou, M. Zhang, X. Qiu, Q. Fan Center of Orthopedic Surgery Orthopedics Oncology Institute of Chinese PLA, Tangdu Hospital,...
View ArticleUsing the body’s own immune system in the fight against cancer
February 8, 2012 DNA sequences from tumor cells can be used to direct the immune system to attack cancer, according to scientists at Washington University School of Medicine in St. Louis. The research,...
View ArticleResearchers find sarcoma tumor immune response with combination therapy
March 1, 2012 in Cancer A team of 18 researchers at Moffitt Cancer Center in Tampa, Fla., have found that treating high-risk, soft tissue sarcoma patients with a combination of implanted dendritic...
View ArticleInsight: New doubts about prostate-cancer vaccine Provenge
Fri, Mar 30 2012 By Sharon Begley NEW YORK (Reuters) – Prostate cancer vaccine Provenge has long incited passions unlike any other cancer therapy. Doctors who raised doubts about it received death...
View Article
More Pages to Explore .....